Checkpoint inhibitor induced myositis - The value of MRI STIR.
Journal
eNeurologicalSci
ISSN: 2405-6502
Titre abrégé: eNeurologicalSci
Pays: Netherlands
ID NLM: 101667077
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
28
10
2022
revised:
29
12
2022
accepted:
31
12
2022
entrez:
23
1
2023
pubmed:
24
1
2023
medline:
24
1
2023
Statut:
epublish
Résumé
•Treatment with immune checkpoint inhibitors can cause serious adverse events.•Myositis combined with myocarditis ad adverse event have a mortality for 50%.•Early diagnosis is important for better outcome.•Employing MRI STIR can rapidly diagnose, guide biopsy, and classify cases of immune-related myositis.
Identifiants
pubmed: 36683900
doi: 10.1016/j.ensci.2022.100442
pii: S2405-6502(22)00051-X
pmc: PMC9849862
doi:
Types de publication
Case Reports
Langues
eng
Pagination
100442Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
We hereby declare that we have no conflicts of interest.
Références
Brain Commun. 2020 Nov 02;2(2):fcaa181
pubmed: 33305263
Clin Radiol. 2021 Jan;76(1):81.e1-81.e10
pubmed: 32958223
Ann Neurol. 2020 May;87(5):659-669
pubmed: 32086972
Curr Opin Rheumatol. 2016 Nov;28(6):625-30
pubmed: 27454210
JAMA Oncol. 2018 Dec 1;4(12):1721-1728
pubmed: 30242316
Neurology. 2018 Sep 4;91(10):e985-e994
pubmed: 30089619
J Immunother Cancer. 2021 Jul;9(7):
pubmed: 34281989
Autoimmun Rev. 2020 Aug;19(8):102586
pubmed: 32535094
J Immunother. 2018 May;41(4):208-211
pubmed: 29200081